Xcout Intel
Celea Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Celea Therapeutics among biotech companies — ranked by similarity to what Celea Therapeutics actually does, not by market-cap band.
Subscribe to see Celea Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Celea Therapeutics
Celea Therapeutics is a biopharmaceutical company focused on advancing transformative treatments for serious respiratory diseases.
Celea Therapeutics at a glance
Celea Therapeutics is a biotech company. Xcout tracks 4 named people at Celea Therapeutics, including Sven Dethlefs (Chief Executive Officer). Xcout recorded 18 job postings from Celea Therapeutics in the last 90 days.
Celea Therapeutics leadership
- Sven DethlefsChief Executive Officer
- Camilla GrahamMedical Affairs
- David GolodClinical Operations & Program Strategy
- Neera JainChemistry, Manufacturing, and Controls
Hiring at Celea Therapeutics
Xcout recorded 18 job postings from Celea Therapeutics in the last 90 days, from a hiring record Xcout has kept since August 2026.
The weekly hiring trend, the roles and locations behind it — see Celea Therapeutics's hiring signals →
Top 12 Celea Therapeutics competitors
Ranked by semantic similarity — how close each company is to Celea Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Sunterra Bio is a biopharmaceutical company focused on developing inhaled small-molecule therapies for rare pulmonary diseases. Headquartered in Carlsbad, California, the company advances targeted treatments for respiratory conditions.
Biotechnology
Altesa BioSciences is a clinical-stage pharmaceutical company headquartered in College Park, Georgia. The company is dedicated to improving the lives of individuals suffering from chronic lung diseases, including conditions such as COPD and asthma.
Biotechnology
Expedition Therapeutics is a clinical-stage biotechnology company headquartered in San Francisco, California, developing novel oral small molecule therapies for serious inflammatory and respiratory diseases.
Biotechnology
Aer Therapeutics, Inc. is a biotechnology research company based in North Carolina focused on targeting mucus to improve lung health.
Similar biotech company
Sionna Therapeutics is a clinical-stage biopharmaceutical company headquartered in Waltham, Massachusetts, focused on developing treatments for cystic fibrosis.
Biotechnology
RaeSedo Holding, Inc. is a biotechnology company developing a novel class of therapeutics for asthma. The company is creating surfactant protein-A (SP-A) derived peptide therapies designed to reduce inflammation, mucus, and airway constriction for asthma patients.
Biotechnology
AeroRx Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing proprietary nebulized combination therapies for chronic obstructive pulmonary disease (COPD).
Biotechnology
Aeglea BioTherapeutics, Inc. is a clinical-stage biopharmaceutical company that has been involved in developing therapeutics and acquiring other ventures.
Biotechnology
Aiolos Bio is a biotechnology research company headquartered in San Francisco, California, focused on developing novel treatments for respiratory and asthma conditions. The clinical-stage biopharmaceutical firm was acquired by GSK to strengthen its drug development pipeline.
Similar biotech company
Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company that engages in the development of products to address pulmonary hypertension related to interstitial lung disease.
Biotechnology
Certa Therapeutics is a private biotechnology company headquartered in Melbourne, Australia, focused on developing innovative precision therapies for the treatment of fibrotic diseases.
Biotechnology
Upstream Bio, Inc. is a biotechnology company in the clinical development stage, dedicated to innovating therapies for inflammatory conditions, particularly those affecting the severe respiratory system. Its pipeline notably features verekitug, a monoclonal antibody designed to selectively target and suppress the thymic stromal lymphopoietin receptor. Beyond this, the company is actively developing treatments for severe asthma, chronic rhinosinusitis with nasal polyps, and chronic obstructive pulmonary disease. Established in 2021, Upstream Bio maintains its operational base in Waltham, Massachusetts.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Celea Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Celea Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →